208
Participants
Start Date
October 31, 2024
Primary Completion Date
February 28, 2026
Study Completion Date
August 31, 2026
activated Light Source (aPDT)
"Application of SW3100 Formulation (0.2% chlorhexidine gluconate and methylene blue) in both nostrils followed by placing the SW3200 Nasal Light Illuminator with one channel per nostril.~Activation of SW4000 Light Source (Class 1 Laser Device) that generates red light consisting of 2 channels of 700 mW, 664 nm light (continuous wave) used to activate the disinfecting formulation.~Duration of illumination 2 minutes"
non activated Light Source (Control)
"Application of SW3100 Formulation (0.2% chlorhexidine gluconate and methylene blue) in both nostrils followed by placing the SW3200 Nasal Light Illuminator with one channel per nostril.~No activation of SW4000 Light Source~Waiting for 2 minutes"
Collaborators (1)
Ondine Biomedical Inc.
INDUSTRY
University Hospital, Zürich, Innovation Pool
UNKNOWN
University of Zurich
OTHER